Who invested in PMV Pharmaceuticals

2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Funding summaryUpdated 26 Oct 2026

$144Mraised across 2 rounds since 2017, from 2 sources

$74MSeries B$70MSeries D

Latest round: Series D, $70MAug 2020
Biggest round: $74MSeries B · Feb 2017
Investors: 6

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2017201820192020

$74MSeries B$70MSeries D

First round: Series B, $74M
Biggest round: $74M
Between rounds: 3.4 years

The rounds

Aug 2020
Series D$70M2 new1 returning
Source recorded
Feb 2017
Series B$74M4 new
- OrbiMed
- Osage University Partners
- Euclidean Capital/ InterWest Partners
- Topspin Biotech Fund
Reported by FinSMEsSEC filing: $74M sold, first sale Feb 2017

Founders and team

From PMV Pharmaceuticals's own website and the SEC filings it signed: 8 on the team.

Jing LiVice President, Product Leader
Laura De LeonVice President, Head of Clinical Development Operations
Shibu SleebaVice President, Information Technology
Michael CarulliChief Financial Officer
Phil HermanChief Commercial Officer
Robert TicktinGeneral Counsel & COO
Laurie StelzerChair, Board of Directors
David MackExecutive Officer, Directori

On the board, as filediArnold LevineArnold OronskyPeter ThompsonSteve Winick

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series B2017Series D2020

OrbiMed

RA Capital Management

Wellington Management

Osage University PartnersEuclidean Capital/ InterWest PartnersTopspin Biotech Fund

Everyone who backed them

OrbiMedPrivate equity2rounds

RA Capital ManagementPrivate equity1round

Wellington ManagementVC firm1round

Osage University PartnersVC firm1round

Euclidean Capital/ InterWest Partnersno record of our own yet1round

Topspin Biotech Fundno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list PMV Pharmaceuticals as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

InterWest PartnersVC firmPer its own site

Nextech InvestPrivate equityPer its own site

Avoro Capital Advi...Private equityPer its own site

Quick answers about PMV Pharmaceuticals

Who invested in PMV Pharmaceuticals?

PMV Pharmaceuticals's investors include OrbiMed, RA Capital Management, Wellington Management, Osage University Partners and Euclidean Capital/ InterWest Partners, and 1 more on record.

How much has PMV Pharmaceuticals raised?

PMV Pharmaceuticals has raised $144M across 2 rounds since 2017.

When did PMV Pharmaceuticals last raise?

PMV Pharmaceuticals's most recent round was a Series D of $70M in Aug 2020.

What was PMV Pharmaceuticals's biggest round?

PMV Pharmaceuticals's largest round on record is $74M (Series B), in Feb 2017.

Who backed PMV Pharmaceuticals first?

PMV Pharmaceuticals's first round on record, in Feb 2017, was backed by OrbiMed, Osage University Partners and Euclidean Capital/ InterWest Partners and 1 others.